The Next Generation of CRISPR-Cas Systems

Researchers reinvent genome editing with new CRISPR-Cas systems.

Written byNathan Ni, PhD
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The ease of use and robustness of CRISPR-Cas technology revolutionized genome editing for research ranging from fundamental science to translational medicine. Initial successes inspired scientists to discover and create new CRISPR systems, including those using Cas9, Cas12, Cascade-Cas3, and Cas13 orthologues. In addition to targeting DNA, researchers developed next-generation CRISPR-Cas systems for RNA targeting, epigenetic modifications, and chromatin interactions, advancing research, medicine, and diagnostics.

Download this poster from The Scientist to learn about the next generation of CRISPR-Cas systems, how they improve biological understanding, and how they propel gene and cell therapy research.

Download:

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Nathan Ni, PhD Headshot

    Nathan Ni is a freelance science writer and editor with a decade of experience in journalism, marketing, and educational works. He earned a PhD in Physiology from Queen's University, where he investigated the role of inflammatory leukotriene pathways in myocardial infarction.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies